论文部分内容阅读
目的:对阿卡波糖联合胰岛素在临床上应用的疗效和安全性进行分析和研究,讨论阿卡波糖对2型糖尿病患者的降糖效果。方法:对在2014年9月-2015年8月我院治疗的2型糖尿病患者的80例患者临床资料进行回顾性分析,并初步探讨患者服用阿卡波糖联合胰岛素的治疗效果。结果:对80例2型糖尿病患者用阿卡波糖联合胰岛素治疗后,患者各时点血糖均有明显下降,且不同患者疗效有明显的差异,经分析后发现服药前血糖水平高、病程短的患者疗效好。结论:阿卡波糖在临床治疗2型糖尿病具有较好的效果,是有效的口服降糖药,但其疗效受服药前一般情况的影响。
OBJECTIVE: To analyze and study the efficacy and safety of acarbose plus insulin in clinical practice and to discuss the hypoglycemic effect of acarbose on type 2 diabetes. Methods: The clinical data of 80 patients with type 2 diabetes mellitus treated in our hospital from September 2014 to August 2015 were analyzed retrospectively. The therapeutic effect of acarbose combined with insulin was also discussed. Results: 80 cases of type 2 diabetes patients treated with acarbose combined with insulin, the patient’s blood glucose at each time were significantly decreased, and the efficacy of different patients were significantly different, the analysis found that high blood sugar levels before treatment, short course of disease The patients have good curative effect. CONCLUSION: Acarbose is effective in treating type 2 diabetes mellitus and is an effective oral hypoglycemic agent. However, its efficacy is affected by the general situation before treatment.